Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894533856> ?p ?o ?g. }
- W2894533856 abstract "Despite development of comprehensive approaches to treat schizophrenia and other psychotic disorders and improve outcomes, there remains a proportion (approximately one-third) of patients who are treatment resistant and will not have remission of psychotic symptoms despite adequate trials of pharmacotherapy. This level of treatment response is stable across all stages of the spectrum of psychotic disorders, including early phase psychosis and chronic schizophrenia. Our current pharmacotherapies are beneficial in decreasing positive symptomology in most cases, however, with little to no impact on negative or cognitive symptoms. Not all individuals with treatment resistant psychosis unfortunately, even benefit from the potential pharmacological reductions in positive symptoms. The existing pharmacotherapy for psychosis is targeted at neurotransmitter receptors. The current first and second generation antipsychotic medications all act on dopamine type 2 receptors with the second generation drugs also interacting significantly with serotonin type 1 and 2 receptors, and with varying pharmacodynamic profiles overall. This focus on developing dopaminergic/serotonergic antipsychotics, while beneficial, has not reduced the proportion of patients experiencing treatment resistance to date. Another pharmacological approach is imperative to address treatment resistance both for response overall and for negative symptoms in particular. Here we review the evidence that white matter abnormalities in the brain may be underlying the symptomology of psychotic disorders and propose that white matter may be a viable pharmacological target for pharmacoresistant schizophrenia." @default.
- W2894533856 created "2018-10-05" @default.
- W2894533856 creator A5048939286 @default.
- W2894533856 creator A5050710884 @default.
- W2894533856 date "2018-10-18" @default.
- W2894533856 modified "2023-09-23" @default.
- W2894533856 title "Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia" @default.
- W2894533856 cites W1022975193 @default.
- W2894533856 cites W1588408616 @default.
- W2894533856 cites W1660075 @default.
- W2894533856 cites W1835574744 @default.
- W2894533856 cites W1842993209 @default.
- W2894533856 cites W1859096132 @default.
- W2894533856 cites W1884769644 @default.
- W2894533856 cites W1966024862 @default.
- W2894533856 cites W1968591849 @default.
- W2894533856 cites W1969132778 @default.
- W2894533856 cites W1969157787 @default.
- W2894533856 cites W1969275043 @default.
- W2894533856 cites W1969365110 @default.
- W2894533856 cites W1970213305 @default.
- W2894533856 cites W1971184451 @default.
- W2894533856 cites W1973476733 @default.
- W2894533856 cites W1975821649 @default.
- W2894533856 cites W1976356661 @default.
- W2894533856 cites W1977089043 @default.
- W2894533856 cites W1978699711 @default.
- W2894533856 cites W1983429451 @default.
- W2894533856 cites W1994238149 @default.
- W2894533856 cites W1994676070 @default.
- W2894533856 cites W1997258174 @default.
- W2894533856 cites W1997525040 @default.
- W2894533856 cites W2004828236 @default.
- W2894533856 cites W2005342508 @default.
- W2894533856 cites W2005347777 @default.
- W2894533856 cites W2008880867 @default.
- W2894533856 cites W2009398661 @default.
- W2894533856 cites W2014659268 @default.
- W2894533856 cites W2017597416 @default.
- W2894533856 cites W2025008591 @default.
- W2894533856 cites W2026527527 @default.
- W2894533856 cites W2029856455 @default.
- W2894533856 cites W2030266450 @default.
- W2894533856 cites W2034367323 @default.
- W2894533856 cites W2036480935 @default.
- W2894533856 cites W2042808677 @default.
- W2894533856 cites W2043935193 @default.
- W2894533856 cites W2055693317 @default.
- W2894533856 cites W2057325906 @default.
- W2894533856 cites W2062251431 @default.
- W2894533856 cites W2062592538 @default.
- W2894533856 cites W2062941476 @default.
- W2894533856 cites W2063001897 @default.
- W2894533856 cites W2065094079 @default.
- W2894533856 cites W2065104854 @default.
- W2894533856 cites W2066738717 @default.
- W2894533856 cites W2068031822 @default.
- W2894533856 cites W2078881206 @default.
- W2894533856 cites W2085360366 @default.
- W2894533856 cites W2087908115 @default.
- W2894533856 cites W2091162149 @default.
- W2894533856 cites W2092644527 @default.
- W2894533856 cites W2092684960 @default.
- W2894533856 cites W2094743387 @default.
- W2894533856 cites W2095651675 @default.
- W2894533856 cites W2100453275 @default.
- W2894533856 cites W2101357408 @default.
- W2894533856 cites W2104719454 @default.
- W2894533856 cites W2105097410 @default.
- W2894533856 cites W2105728290 @default.
- W2894533856 cites W2108968692 @default.
- W2894533856 cites W2114074237 @default.
- W2894533856 cites W2116431283 @default.
- W2894533856 cites W2116538730 @default.
- W2894533856 cites W2119578441 @default.
- W2894533856 cites W2121612791 @default.
- W2894533856 cites W2132748057 @default.
- W2894533856 cites W2135533078 @default.
- W2894533856 cites W2135689380 @default.
- W2894533856 cites W2136304583 @default.
- W2894533856 cites W2137497269 @default.
- W2894533856 cites W2137609561 @default.
- W2894533856 cites W2139956925 @default.
- W2894533856 cites W2140606211 @default.
- W2894533856 cites W2141782996 @default.
- W2894533856 cites W2143635299 @default.
- W2894533856 cites W2144198011 @default.
- W2894533856 cites W2151243338 @default.
- W2894533856 cites W2151593200 @default.
- W2894533856 cites W2153518194 @default.
- W2894533856 cites W2156295356 @default.
- W2894533856 cites W2157860240 @default.
- W2894533856 cites W2159970958 @default.
- W2894533856 cites W2162752850 @default.
- W2894533856 cites W2164774937 @default.
- W2894533856 cites W2166256285 @default.
- W2894533856 cites W2166478103 @default.
- W2894533856 cites W2175578939 @default.
- W2894533856 cites W2178386353 @default.
- W2894533856 cites W2192944506 @default.